Literature DB >> 32373667

A Case of Generalized Chorea Presenting as an Early Feature of Fragile-X Associated Tremor/Ataxia Syndrome.

Fariha Islam1, Will Lee1.   

Abstract

Entities:  

Keywords:  FMR1; FXTAS; chorea; dementia; fragile x‐tremor ataxia syndrome

Year:  2020        PMID： 32373667      PMCID： PMC7197300          DOI： 10.1002/mdc3.12944

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN： 2330-1619


× No keyword cloud information.
  10 in total

1.  Spastic paraparesis, cerebellar ataxia, and intention tremor: a severe variant of FXTAS?

Authors:  S Jacquemont; A Orrico; L Galli; P K Sahota; J A Brunberg; C Anichini; M Leehey; S Schaeffer; R J Hagerman; P J Hagerman; F Tassone
Journal:  J Med Genet       Date:  2005-02       Impact factor: 6.318

2.  The variable phenotype of FXTAS: a common cause of "idiopathic" disorders.

Authors:  Christoph Kamm; Thomas Gasser
Journal:  Neurology       Date:  2005-07-26       Impact factor: 9.910

Review 3.  Fragile X syndrome: an update and review for the primary pediatrician.

Authors:  Jeannie Visootsak; Stephen T Warren; Aimee Anido; John M Graham
Journal:  Clin Pediatr (Phila)       Date:  2005-06       Impact factor: 1.168

4.  Atypical clinical course of FXTAS: rapidly progressive dementia as the major symptom.

Authors:  M R R Gonçalves; L P Capelli; R Nitrini; E R Barbosa; C S Porto; L T Lucato; A M Vianna-Morgante
Journal:  Neurology       Date:  2007-05-22       Impact factor: 9.910

5.  Pure psychiatric presentation of Fragile X-associated tremor/ataxia syndrome.

Authors:  P Reiner; I Taifas; H Massiou; E Jouvent
Journal:  Eur J Neurol       Date:  2013-09       Impact factor: 6.089

6.  FXTAS: new insights and the need for revised diagnostic criteria.

Authors:  Emmanuelle Apartis; Anne Blancher; Wassilios G Meissner; Lucie Guyant-Maréchal; David Maltête; Thomas De Broucker; André-Pierre Legrand; Hichem Bouzenada; Hung Tran Thanh; Magali Sallansonnet-Froment; Adrien Wang; François Tison; Carole Roué-Jagot; Frédéric Sedel; Perrine Charles; Sandra Whalen; Delphine Héron; Stéphane Thobois; Alice Poisson; Gaetan Lesca; Anne-Marie Ouvrard-Hernandez; Valérie Fraix; Stephane Palfi; Marie-Odile Habert; Bertrand Gaymard; Jean-Claude Dussaule; Pierre Pollak; Marie Vidailhet; Alexandra Durr; Jean-Claude Barbot; Véronique Gourlet; Alexis Brice; Mathieu Anheim
Journal:  Neurology       Date:  2012-10-17       Impact factor: 9.910

7.  Fragile X-associated tremor/ataxia syndrome (FXTAS) in grey zone carriers.

Authors:  Y Liu; T I Winarni; L Zhang; F Tassone; R J Hagerman
Journal:  Clin Genet       Date:  2012-10-17       Impact factor: 4.438

Review 8.  Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome.

Authors:  Randi Hagerman; Paul Hagerman
Journal:  Lancet Neurol       Date:  2013-08       Impact factor: 44.182

9.  The primary cognitive deficit among males with fragile X-associated tremor/ataxia syndrome (FXTAS) is a dysexecutive syndrome.

Authors:  Angela G Brega; Glenn Goodrich; Rachael E Bennett; David Hessl; Karen Engle; Maureen A Leehey; Lanee S Bounds; Marsha J Paulich; Randi J Hagerman; Paul J Hagerman; Jennifer B Cogswell; Flora Tassone; Ann Reynolds; Robert Kooken; Michael Kenny; Jim Grigsby
Journal:  J Clin Exp Neuropsychol       Date:  2008-02-15       Impact factor: 2.475

10.  Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates.

Authors:  Sébastien Jacquemont; Randi J Hagerman; Maureen Leehey; Jim Grigsby; Lin Zhang; James A Brunberg; Claudia Greco; Vincent Des Portes; Tristan Jardini; Richard Levine; Elizabeth Berry-Kravis; W Ted Brown; Stephane Schaeffer; John Kissel; Flora Tassone; Paul J Hagerman
Journal:  Am J Hum Genet       Date:  2003-03-12       Impact factor: 11.025
  10 in total
  1 in total

Review 1.  Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): A Gender Perspective.

Authors:  Daniele Orsucci; Lucia Lorenzetti; Fulvia Baldinotti; Andrea Rossi; Edoardo Vitolo; Fabio Luigi Gheri; Alessandro Napolitano; Giancarlo Tintori; Marco Vista
Journal:  J Clin Med       Date:  2022-02-15       Impact factor: 4.241
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.